“How can Latin-American academic research laboratories participate in the discovery and development of next generation medicines?”
Organizers
Gaston Soria, Ricardo M. Biondi and Hugo Gramajo
The main objective of the workshop is to establish a Network of Argentine and Latin-American scientists with interests in different aspects of small molecule drug discovery: target validation, biochemistry, chemical biology, screening of compounds libraries, structural biology, in silico/modeling, drug repurposing, and preclinical studies/ in vivo models.
We envisage the 1st Workshop in Drug Discovery to be remembered as the “kick-off” of a network that will help catalyze future Argentine and Latin American cooperative participation in different aspects of chemical biology and on the discovery and development of new small molecule drugs.
Program
Lectures
Confirmed International speakers:
1- Gerard Drewes.
​
"Target identification and target validation by chemical proteomics"
​
Senior Director and Head of Chemical Genomics at Cellzome, Cellzome - a GlaxoSmithKline company, EMBL campus, Heidelberg, Germany. Cellzome is a leader in Chemoproteomics. Drug Discovery scientist with a wide range of experience in preclinical research. Line and matrix management of large cross-functional teams. Strong scientific background in neurodegenerative and inflammatory disease. Specific skills in enzymology, pharmacology, and genomics/systems biology. Keen interest in Intellectual Property, Technology Transfer and the Life Science business.
2- Bert Klebl. Director of Lead Discovery Center, an organization that has helped academic laboratories to take their discoveries into the next stage, to outsource drug development projects to industry.
Poster sessions, short talks of selected applicants, and closing roundtables.
The spirit of the meeting is to develop a network that facilitates collaborations the short talks will be selected from abstracts that show techniques or specific know how that can be shared to help move projects forward.
Consults: DrugDiscoverySAIB2019@gmail.com.
“How can Latin-American academic research laboratories participate in the discovery and development of next generation medicines?”
Organizers
Gaston Soria, Ricardo M. Biondi and Hugo Gramajo
The main objective of the workshop is to establish a Network of Argentine and Latin-American scientists with interests in different aspects of small molecule drug discovery: target validation, biochemistry, chemical biology, screening of compounds libraries, structural biology, in silico/modeling, drug repurposing, and preclinical studies/ in vivo models.
We envisage the 1st Workshop in Drug Discovery to be remembered as the “kick-off” of a network that will help catalyze future Argentine and Latin American cooperative participation in different aspects of chemical biology and on the discovery and development of new small molecule drugs.
Program
Lectures
Confirmed International speakers:
1- Gerard Drewes.
​
"Target identification and target validation by chemical proteomics"
​
Senior Director and Head of Chemical Genomics at Cellzome, Cellzome - a GlaxoSmithKline company, EMBL campus, Heidelberg, Germany. Cellzome is a leader in Chemoproteomics. Drug Discovery scientist with a wide range of experience in preclinical research. Line and matrix management of large cross-functional teams. Strong scientific background in neurodegenerative and inflammatory disease. Specific skills in enzymology, pharmacology, and genomics/systems biology. Keen interest in Intellectual Property, Technology Transfer and the Life Science business.
2- Bert Klebl. Director of Lead Discovery Center, an organization that has helped academic laboratories to take their discoveries into the next stage, to outsource drug development projects to industry.
Poster sessions, short talks of selected applicants, and closing roundtables.
The spirit of the meeting is to develop a network that facilitates collaborations the short talks will be selected from abstracts that show techniques or specific know how that can be shared to help move projects forward.
Consults: DrugDiscoverySAIB2019@gmail.com.
“How can Latin-American academic research laboratories participate in the discovery and development of next generation medicines?”
Organizers
Gaston Soria, Ricardo M. Biondi and Hugo Gramajo
The main objective of the workshop is to establish a Network of Argentine and Latin-American scientists with interests in different aspects of small molecule drug discovery: target validation, biochemistry, chemical biology, screening of compounds libraries, structural biology, in silico/modeling, drug repurposing, and preclinical studies/ in vivo models.
We envisage the 1st Workshop in Drug Discovery to be remembered as the “kick-off” of a network that will help catalyze future Argentine and Latin American cooperative participation in different aspects of chemical biology and on the discovery and development of new small molecule drugs.
Program
Lectures
Confirmed International speakers:
1- Gerard Drewes.
​
"Target identification and target validation by chemical proteomics"
​
Senior Director and Head of Chemical Genomics at Cellzome, Cellzome - a GlaxoSmithKline company, EMBL campus, Heidelberg, Germany. Cellzome is a leader in Chemoproteomics. Drug Discovery scientist with a wide range of experience in preclinical research. Line and matrix management of large cross-functional teams. Strong scientific background in neurodegenerative and inflammatory disease. Specific skills in enzymology, pharmacology, and genomics/systems biology. Keen interest in Intellectual Property, Technology Transfer and the Life Science business.
2- Bert Klebl. Director of Lead Discovery Center, an organization that has helped academic laboratories to take their discoveries into the next stage, to outsource drug development projects to industry.
Poster sessions, short talks of selected applicants, and closing roundtables.
The spirit of the meeting is to develop a network that facilitates collaborations the short talks will be selected from abstracts that show techniques or specific know how that can be shared to help move projects forward.
Consults: DrugDiscoverySAIB2019@gmail.com.
“How can Latin-American academic research laboratories participate in the discovery and development of next generation medicines?”
Organizers
Gaston Soria, Ricardo M. Biondi and Hugo Gramajo
The main objective of the workshop is to establish a Network of Argentine and Latin-American scientists with interests in different aspects of small molecule drug discovery: target validation, biochemistry, chemical biology, screening of compounds libraries, structural biology, in silico/modeling, drug repurposing, and preclinical studies/ in vivo models.
We envisage the 1st Workshop in Drug Discovery to be remembered as the “kick-off” of a network that will help catalyze future Argentine and Latin American cooperative participation in different aspects of chemical biology and on the discovery and development of new small molecule drugs.
Program
Lectures
Confirmed International speakers:
1- Gerard Drewes.
​
"Target identification and target validation by chemical proteomics"
​
Senior Director and Head of Chemical Genomics at Cellzome, Cellzome - a GlaxoSmithKline company, EMBL campus, Heidelberg, Germany. Cellzome is a leader in Chemoproteomics. Drug Discovery scientist with a wide range of experience in preclinical research. Line and matrix management of large cross-functional teams. Strong scientific background in neurodegenerative and inflammatory disease. Specific skills in enzymology, pharmacology, and genomics/systems biology. Keen interest in Intellectual Property, Technology Transfer and the Life Science business.
2- Bert Klebl. Director of Lead Discovery Center, an organization that has helped academic laboratories to take their discoveries into the next stage, to outsource drug development projects to industry.
Poster sessions, short talks of selected applicants, and closing roundtables.
The spirit of the meeting is to develop a network that facilitates collaborations the short talks will be selected from abstracts that show techniques or specific know how that can be shared to help move projects forward.
Consults: DrugDiscoverySAIB2019@gmail.com.
1ST WORKSHOP ON DRUG DISCOVERY
“How can Latin-American academic research laboratories participate in the discovery and development of next generation medicines?”
November 5, 2019, 9 - 16 hs
9-16
Organizers
Gaston Soria, Ricardo M. Biondi and Hugo Gramajo
The main objective of the workshop is to establish a Network of Argentine and Latin-American scientists with interests in different aspects of small molecule drug discovery: target validation, biochemistry, chemical biology, screening of compounds libraries, structural biology, in silico/modeling, drug repurposing, and preclinical studies/ in vivo models.
We envisage the 1st Workshop in Drug Discovery to be remembered as the “kick-off” of a network that will help catalyze future Argentine and Latin American cooperative participation in different aspects of chemical biology and on the discovery and development of new small molecule drugs.
Program
Lectures
Confirmed International speakers:
Gerard Drewes
​​
"Target identification and target validation by chemical proteomics"
​Senior Director and Head of Chemical Genomics at Cellzome, Cellzome - a GlaxoSmithKline company, EMBL campus, Heidelberg, Germany. Cellzome is a leader in Chemoproteomics. Drug Discovery scientist with a wide range of experience in preclinical research. Line and matrix management of large cross-functional teams. Strong scientific background in neurodegenerative and inflammatory disease. Specifiskills in enzymology, pharmacology, and genomics/systems biology. Keen interest in Intellectual Property, Technology Transfer and the Life Science business.
​
Bert Klebl
Bert Klebl, leads the Lead Discovery Center (LDC, Dortmund) an organization created by the Max Planck Society specialized in advancing basic discoveries into new medicines. The LDC takes projects through the discovery and development process into "advanced leads" and clinical candidates that are then licensed to the pharmaceutical industry to continue through pre-clinical /clinical studies. The LDC has a very unique approach to the Discovery and Development of new drugs and its results are extraordinary. To date the LDC has licensed 18 Drug Development programs to the pharmaceutical industry. Bert Klebl and Gerard Drewes will present talks, visit our posters and then head Discussion Roundtables
​
​
Workshop language: Speakers will present in English
Poster sessions, short talks and closing roundtables.
​
Short talks will be selected from the submitted Posters Abstracts
The abstracts can be submitted from 1 to 10 september
The spirit of the meeting is to develop a network that facilitates collaborations. The short talks will be selected from abstracts that show techniques or specific know-how that can be shared to help move projects forward.
​
Contact: DrugDiscoverySAIB2019@gmail.com.
​
​